Peptide conjugation techniques are advancing CNS delivery of oligonucleotides, addressing blood-brain barrier challenges and improving therapeutic outcomes.
11d
Denali Therapeutics Inc. (DNLI) Presents at TD Cowen 46th Annual Health Care Conference Transcript
TD Cowen 46th Annual Health Care Conference March 4, 2026 9:50 AM ESTCompany ParticipantsAlexander Schuth - Co-Founder, ...
TD Cowen 46th Annual Health Care Conference March 3, 2026 3:10 PM ESTCompany ParticipantsEric BrownGiacomo Salvadore - Chief ...
Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and siRNA, with continued progress across AL137 (ABC-enabled anti-amyloid ...
Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...
One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others. A study published in Nature Communications, by a multidisciplinary team ...
MGS says Auto-injector Reimagined drug-delivery device, which harnesses its design and moldmaking capabilities, can help ...
In physics, the mesoscale lies between the microscopic and the macroscopic. It is not just the domain of tiny living ...
Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high therapeutic efficacy.
Scientists have developed an adaptable materials platform that can safely and efficiently deliver a wide range of genetic medicines, an advance that could accelerate the development of next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results